Photo via Fast Company
According to Scott Stevenson, CEO of Spellbook, a legal technology startup, many AI startups are misrepresenting their financial performance to attract venture capital investment. In recent comments, Stevenson highlighted how some companies blur the line between actual recurring revenue (ARR) and contracted revenue (CARR) when pitching to investors and media, often presenting inflated figures as legitimate annual recurring revenue. For Charlotte-area investors and business leaders evaluating AI startups, understanding this distinction is critical to avoiding overvaluation traps.
The core issue centers on how startups calculate and present their revenue metrics. Annual recurring revenue is designed to reflect money that's actually being invoiced and collected from customers on a recurring basis. Contracted annually recurring revenue, by contrast, includes future payments from signed agreements that may never materialize. Stevenson noted that the gap between these figures can be as much as 3 to 5 times, with some startups conflating the two metrics in press releases while keeping them separate in investor pitches. Examples include counting free trial periods as revenue, projecting income from features not yet built, or assuming customers won't cancel even when contracts allow it.
This practice has gained traction across the startup ecosystem and is creating a ripple effect. Both established venture capital firms and newer investors have acknowledged the prevalence of the issue, yet some appear reluctant to publicly call it out. The danger, Stevenson warned, is that when one startup in a category inflates its numbers, competitors feel pressured to do the same to avoid appearing smaller or less successful. This can lead to irrational decision-making, excessive risk-taking, and distorted market benchmarks that affect both employees who don't understand the real numbers and customers trying to assess the competitive landscape.
For Charlotte's business community, this cautionary tale underscores the importance of diligence when evaluating AI startups seeking funding or partnership. Investors and corporate leaders should ask pointed questions about whether reported revenue is truly "live"—meaning invoiced and collectable—or if it includes projected future revenue. As skepticism about AI company valuations already runs high, distinguishing genuine revenue growth from inflated metrics becomes essential for making sound investment decisions in the rapidly evolving technology sector.
